SCI & TECH● LOWSep 30 · Sep 30, 2026, 2:32 PM
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
CNBC · global
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH46m agoEurope's answer to Starlink: Who is building IRIS² and what is Germany's roleEuroNews [en]SCI & TECH1h ago [ OPINION ] The weakest link may not be the subsea cablesrappler.com · PhilippinesSCI & TECH1h agoWho is Nathan Chen, the Chinese teen AI prodigy being courted by Silicon Valley?South China Morning PostSCI & TECH1h ago'Well, it worked': Elon Musk unveils new Tesla Roadster that can flyEuroNews [en]